CeLLogix

Allogeneic Bone Scaffold

CeLLogix contains viable bone-derived cells that promote strong, natural bone growth.

  • Demineralized bone scaffold with osteoinductive potential, which provides exposure of signaling molecules and bone morphogenetic proteins¹

  • Proprietary, optimized bone microparticulate size range of 100-300 μm²

  • Convenient handling and preparation time in the OR

  • Average cell viability exceeds 80% post-thaw³

  • Product shelf-life is two years from date of processing when stored at -65°C or colder

  • Osteoconductive three-dimensional scaffold with cortical & cancellous components

  • DMSO-free cryoprotectant with no rinsing and decanting steps required

  • Bone-derived cells to support osteogenic healing processes

  • Four hour working window for implantation after thaw without loss of cell viability

  • Minimum of 150,000 viable cells per cc of allograft post-thaw³

CeLLogix Product Features

Resources

CeLLogix Brochure

Need more information on our Spinal Implant Solutions?

Reference

1. Study evaluated the bone ongrowth of PEEK-OPTIMA and PEEK-OPTIMA HA Enhanced in a bone defect model in sheep. Data on file at Invibio. This has not been correlated with human clinical experience.
2. J. Henkel, M. A. Woodruff, D. R. Epari, R. Steck, V. Glatt, I. C. Dickinson, P. F. M. Choong, M. A. Schuetz, D. W. Hutmacher. Bone Regeneration Based on Tissue Engineering Conceptions — A 21st Century Perspective. Bone Research (2013) 1, 216–248.